Back to calendar
Fate Therapeutics, Inc. (FATE) Earnings
FATE reports earnings on Thursday, August 13, 2026
earnings report
August 13, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.27
Actual EPS: $-0.26
EPS surprise: 7.14%
Company overview
Market Cap$315.9M
PriceUSD 2.71
EPS (TTM)-1.09
52-week high3.23
52-week low0.93
SectorHealth Technology
IndustryBiotechnology
Employees161